Medical Data Vision Co., Ltd. (3902.T)
- Previous Close
602.00 - Open
598.00 - Bid 590.00 x --
- Ask 592.00 x --
- Day's Range
590.00 - 604.00 - 52 Week Range
541.00 - 863.00 - Volume
91,200 - Avg. Volume
173,680 - Market Cap (intraday)
22.574B - Beta (5Y Monthly) 0.72
- PE Ratio (TTM)
23.04 - EPS (TTM)
25.65 - Earnings Date May 13, 2024
- Forward Dividend & Yield 13.00 (2.16%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
710.00
Medical Data Vision Co., Ltd. develops, produces, maintains, and sells medical information integration systems in Japan. The company offers medical data analysis, research, and consulting services; financial consulting services for medical institutions and hospitals; and medical data services, as well as plans, designs, develops, and operates portal sites. It provides its services to pharmaceutical companies, medical device manufacturers, academia, research institutions, and health insurance companies. Medical Data Vision Co., Ltd. was incorporated in 2003 and is headquartered in Tokyo, Japan.
www.mdv.co.jp262
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 3902.T
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3902.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3902.T
Valuation Measures
Market Cap
22.99B
Enterprise Value
19.78B
Trailing P/E
23.49
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.58
Price/Book (mrq)
5.41
Enterprise Value/Revenue
3.08
Enterprise Value/EBITDA
10.56
Financial Highlights
Profitability and Income Statement
Profit Margin
15.25%
Return on Assets (ttm)
19.91%
Return on Equity (ttm)
24.11%
Revenue (ttm)
6.42B
Net Income Avi to Common (ttm)
979M
Diluted EPS (ttm)
25.65
Balance Sheet and Cash Flow
Total Cash (mrq)
3.22B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
1.59B
Research Analysis: 3902.T
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 3902.T
3902.T does not have Company Insights